In the fourth quarter of 2021, Moderna achieved a profit of $4.87 billion compared with a loss of $272 million in 2020. Total revenue increased from...
In February 2021, Rovi announced that it expected operating income for the current fiscal year to increase by 20% to 30%, including the production of Moderna's...
The results of the clinical trials conducted by Moderna, showed that its COVID-19 vaccine candidate is very efficient. In the group age 18 -64, the efficacy...